OraSure Technologies

Yahoo Finance • 20 days ago

Exclusive-Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

By Svea Herbst-Bayliss NEW YORK (Reuters) -Altai Capital Management is preparing to launch a board fight at OraSure Technologies after the hedge fund, already one of the biggest owners of the medical device maker, increased its holdings,... Full story

Yahoo Finance • 2 months ago

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

Earnings Call Insights: OraSure Technologies (OSUR) Q2 2025 MANAGEMENT VIEW * CEO Carrie Eglinton Manner highlighted progress on OraSure’s three-pillar strategy: "strengthening our foundation; two, elevating our core growth; and three,... Full story

Yahoo Finance • 2 months ago

OraSure Appoints Anne Messing as Chief Commercial Officer

BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as... Full story

Yahoo Finance • 2 months ago

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • 3 months ago

Orasure gets takeover bid proposal from Ron Zwanziger- Reuters

[The concept of the word M&A on cubes on a beautiful green background] Zhanna Hapanovich/iStock via Getty Images Healthcare entrepreneur Ron Zwanziger recently made an unsolicited offer to buy OraSure Technologies, a company known for its... Full story

Yahoo Finance • 3 months ago

OraSure Launches Blood Collection Tube For High-Quality Proteomic Research

(RTTNews) - OraSure Technologies, Inc. (OSUR), a leader in point-of-need diagnostics and sample management, has introduced the HEMAcollect PROTEIN blood collection tube - BCT to address the growing demands of proteomic researchers. Develo... Full story

Yahoo Finance • 3 months ago

OraSure Launches Novel Blood Collection Device for Proteomic Research

BETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its HEMAcollect™●PROT... Full story

Yahoo Finance • 4 months ago

Evercore says 23andMe buyout removes downside case for OraSure

Evercore ISI believes Regeneron’s (REGN) acquisition of 23andMe for $256M announcement should remove the downside scenario where OraSure’s (OSUR) 23andMe contribution will be zero into perpetuity. Instead, the firm expects 23andMe should c... Full story

Yahoo Finance • 5 months ago

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • 6 months ago

OraSure Announces $40 Million Stock Repurchase Program

BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Director... Full story

Yahoo Finance • 7 months ago

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • 12 months ago

OraSure Technologies Inc. (OSUR): Among the Most Profitable Penny Stocks to Invest In

We recently compiled a list of the 8 Most Profitable Penny Stocks To Invest In.In this article, we are going to take a look at where OraSure Technologies Inc. (NASDAQ:OSUR) stands against the other profitable penny stocks. Potential in Sm... Full story

Yahoo Finance • 2 years ago

OraSure to Participate in Upcoming Investor Conferences

BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today annou... Full story

Yahoo Finance • 2 years ago

Q3 2023 OraSure Technologies Inc Earnings Call

Participants Carrie Eglinton Manner; President, CEO & Director; OraSure Technologies, Inc. Jason Plagman Kenneth J. McGrath; CFO; OraSure Technologies, Inc. Andrew Harris Cooper; Research Analyst; Raymond James & Associates, Inc., Rese... Full story

Yahoo Finance • 2 years ago

OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year

Q3 GAAP EPS of $0.15; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home... Full story

Yahoo Finance • 2 years ago

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain business developments for 5:00 pm ET... Full story

Yahoo Finance • 2 years ago

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

BETHLEHEM, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies and microbiome-focused bioco... Full story

Yahoo Finance • 2 years ago

Can Mixed Fundamentals Have A Negative Impact on OraSure Technologies, Inc. (NASDAQ:OSUR) Current Share Price Momentum?

Most readers would already be aware that OraSure Technologies' (NASDAQ:OSUR) stock increased significantly by 48% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a c... Full story

Yahoo Finance • 2 years ago

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

InteliSwab® test revenue of $118.3 million in Q1, up 33% sequentially; Company delivers cost savings and begins to taper InteliSwab® test production and expenses Gross margins increase 200 basis points sequentially despite mix/pricing hea... Full story

Yahoo Finance • 2 years ago

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET

BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. E... Full story